Dong‐Sheng Pei

4.6k total citations · 1 hit paper
149 papers, 3.5k citations indexed

About

Dong‐Sheng Pei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dong‐Sheng Pei has authored 149 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Molecular Biology, 42 papers in Cancer Research and 40 papers in Oncology. Recurrent topics in Dong‐Sheng Pei's work include RNA modifications and cancer (26 papers), Ubiquitin and proteasome pathways (20 papers) and Cancer-related molecular mechanisms research (20 papers). Dong‐Sheng Pei is often cited by papers focused on RNA modifications and cancer (26 papers), Ubiquitin and proteasome pathways (20 papers) and Cancer-related molecular mechanisms research (20 papers). Dong‐Sheng Pei collaborates with scholars based in China, United States and India. Dong‐Sheng Pei's co-authors include Junnian Zheng, Junnian Zheng, Fu‐Chun Huo, Man-Ru Liu, Wen-Tao Zhu, Zhi‐Man Zhu, Jie Mou, Qiu‐Hua Guan, Guangyi Zhang and Huizhong Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemistry.

In The Last Decade

Dong‐Sheng Pei

145 papers receiving 3.5k citations

Hit Papers

System Xc−: a key regulatory target of ferroptosis in cancer 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. System Xc−: a key regulatory target of ferroptosis in cancer
    2021 188 citations Man-Ru Liu, Dong‐Sheng Pei et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong‐Sheng Pei China 33 2.4k 984 729 375 321 149 3.5k
Sang‐Gu Hwang South Korea 38 2.4k 1.0× 826 0.8× 913 1.3× 325 0.9× 329 1.0× 123 3.9k
Sheng Li China 32 2.2k 0.9× 763 0.8× 548 0.8× 341 0.9× 280 0.9× 155 3.6k
Markus D. Siegelin United States 39 2.7k 1.1× 1.0k 1.0× 786 1.1× 354 0.9× 382 1.2× 109 4.1k
Yonghe Li United States 35 2.4k 1.0× 715 0.7× 807 1.1× 327 0.9× 340 1.1× 57 3.7k
You Mie Lee South Korea 40 3.4k 1.4× 1.5k 1.5× 777 1.1× 378 1.0× 506 1.6× 119 5.0k
John Brognard United States 25 3.7k 1.5× 658 0.7× 1.0k 1.4× 464 1.2× 301 0.9× 50 4.5k
Bangyan L. Stiles United States 30 3.1k 1.3× 895 0.9× 871 1.2× 341 0.9× 335 1.0× 57 4.7k
Sergio Marchini Italy 33 2.0k 0.8× 1.3k 1.3× 970 1.3× 515 1.4× 273 0.9× 105 3.6k
Wassim Abou‐Kheir Lebanon 33 1.4k 0.6× 800 0.8× 740 1.0× 545 1.5× 294 0.9× 113 3.2k
Liankun Sun China 37 2.6k 1.1× 1.1k 1.1× 506 0.7× 344 0.9× 311 1.0× 123 4.1k

Countries citing papers authored by Dong‐Sheng Pei

Since Specialization
Citations

This map shows the geographic impact of Dong‐Sheng Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Sheng Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Sheng Pei more than expected).

Fields of papers citing papers by Dong‐Sheng Pei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Sheng Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Sheng Pei. The network helps show where Dong‐Sheng Pei may publish in the future.

Co-authorship network of co-authors of Dong‐Sheng Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Sheng Pei. A scholar is included among the top collaborators of Dong‐Sheng Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Sheng Pei. Dong‐Sheng Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Zhi‐Man, et al.. (2025). METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14. International Journal of Biological Macromolecules. 309(Pt 2). 142880–142880.
2.
Xu, Nan, Yanan Wu, Lu Wang, et al.. (2025). Assessments of lung nodules by an artificial intelligence chatbot using longitudinal CT images. Cell Reports Medicine. 6(3). 101988–101988. 6 indexed citations
3.
Zhang, Lin, Yuting Xu, Zitong Liu, et al.. (2024). YTHDF1 facilitates esophageal cancer progression via augmenting m6A-dependent TINAGL1 translation. Cellular Signalling. 122. 111332–111332. 3 indexed citations
4.
Ding, Lina, R Zhang, Wenqi Du, Qingling Wang, & Dong‐Sheng Pei. (2024). The role of cGAS-STING signaling pathway in ferroptosis. Journal of Advanced Research. 76. 219–231. 6 indexed citations
5.
Guo, Yan, Xin Hu, Dong‐Sheng Pei, et al.. (2024). Extraction, purification, and mechanism of immunomodulatory peptides obtained from silkworm pupa protein hydrolysate. International Journal of Biological Macromolecules. 283(Pt 3). 137863–137863. 3 indexed citations
6.
7.
Zhu, Zhi‐Man, et al.. (2023). Crosstalk between m6A modification and alternative splicing during cancer progression. Clinical and Translational Medicine. 13(10). e1460–e1460. 51 indexed citations
8.
Liao, Meijian, Xiaolin Sun, Mengdi Wu, et al.. (2023). LINC00922 decoys SIRT3 to facilitate the metastasis of colorectal cancer through up-regulation the H3K27 crotonylation of ETS1 promoter. Molecular Cancer. 22(1). 163–163. 29 indexed citations
9.
Pan, Yao‐Jie, Bowen Liu, & Dong‐Sheng Pei. (2022). The Role of Alternative Splicing in Cancer: Regulatory Mechanism, Therapeutic Strategy, and Bioinformatics Application. DNA and Cell Biology. 41(9). 790–809. 1 indexed citations
10.
Huo, Fu‐Chun, Min Xie, Zhi‐Man Zhu, Junnian Zheng, & Dong‐Sheng Pei. (2022). SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT. Genomics. 114(4). 110424–110424. 14 indexed citations
11.
Yang, Ting, Pei-Cong Shi, Man-Ru Liu, et al.. (2020). Long noncoding RNA MAPKAPK5-AS1 promotes colorectal cancer progression by cis-regulating the nearby gene MK5 and acting as a let-7f-1-3p sponge. Journal of Experimental & Clinical Cancer Research. 39(1). 139–139. 46 indexed citations
12.
Zhang, Dingguo, Jinling Zhang, Linlin Mao, et al.. (2015). p21-Activated kinase 5 affects cisplatin-induced apoptosis and proliferation in hepatocellular carcinoma cells. Tumor Biology. 36(5). 3685–3691. 17 indexed citations
13.
Tian, Hui, Baofu Zhang, Huizhong Li, et al.. (2014). Melanoma Differentiation Associated Gene-7/Interleukin-24 Induces Caspase-3 Denitrosylation to Facilitate the Activation of Cancer Cell Apoptosis. Journal of Interferon & Cytokine Research. 35(3). 157–167. 15 indexed citations
14.
Pei, Dong‐Sheng, Zhi‐Xia Yang, Baofu Zhang, et al.. (2012). Enhanced Apoptosis-Inducing Function of MDA-7/IL-24 RGD Mutant Via the Increased Adhesion to Tumor Cells. Journal of Interferon & Cytokine Research. 32(2). 66–73. 13 indexed citations
15.
Zhang, Baofu, Jun-Jie Liu, Dong‐Sheng Pei, et al.. (2011). Potent Antitumor Effect Elicited by RGD- mda-7 , an mda-7 /IL-24 Mutant, via Targeting the Integrin Receptor of Tumor Cells. Cancer Biotherapy and Radiopharmaceuticals. 26(5). 647–655. 14 indexed citations
16.
Pei, Dong‐Sheng, et al.. (2011). Analysis of human Ki-67 gene promoter and identification of the Sp1 binding sites for Ki-67 transcription. Tumor Biology. 33(1). 257–266. 14 indexed citations
17.
Pei, Dong‐Sheng & Junnian Zheng. (2010). Oncolytic adenoviruses expressing interleukin: a novel antitumour approach. Expert Opinion on Biological Therapy. 10(6). 917–926. 4 indexed citations
18.
Zheng, Junnian, Dong‐Sheng Pei, Baofu Zhang, et al.. (2009). Inhibition of renal cancer cell growth by oncolytic adenovirus armed short hairpin RNA targeting hTERT gene. Cancer Biology & Therapy. 8(1). 84–91. 26 indexed citations
19.
Pei, Dong‐Sheng, et al.. (2006). Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3-K/Akt during cerebral ischemia in rat hippocampus. Neuroscience Letters. 404(1-2). 98–102. 35 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sang‐Gu Hwang Breakdown of academic impact, for papers by Sheng Li Breakdown of academic impact, for papers by Markus D. Siegelin Breakdown of academic impact, for papers by Yonghe Li Breakdown of academic impact, for papers by You Mie Lee Breakdown of academic impact, for papers by John Brognard Breakdown of academic impact, for papers by Bangyan L. Stiles Breakdown of academic impact, for papers by Sergio Marchini Breakdown of academic impact, for papers by Wassim Abou‐Kheir Breakdown of academic impact, for papers by Liankun Sun
Rankless by CCL
2026